BG Medicine has appointed Charles Abdalian to executive vice president and chief financial officer. He joins the company from Knome, where he served as chief financial officer.
He is replacing Michael Rogers, who is leaving the company.
Previously, Abdalian was senior vice president and chief financial officer of Molecular Insight Pharmaceuticals, senior vice president and chief financial officer at Coley Pharmaceutical Group, and president and CEO of Pelias Technologies.
He holds a BS in business administration from Norwich University and an MBA from the Wharton School of the University of Pennsylvania.